hrp0097p1-523 | Growth and Syndromes | ESPE2023

A rare occurrence of non-classic congenital adrenal hyperplasia and type 1 diabetes mellitus in a girl with Prader-Willi Syndrome: Case report and review of the literature

Aureli Alessia , Bocchini Sarah , Mariani Michela , Crinò Antonino , Cappa Marco , Fintini Danilo

Prader–Willi syndrome (PWS) is a rare genetic disorder resulting from lack of expression of the paternally derived chromosome 15q11–13, associated with several complications, including pubertal disorders, short stature, hyperphagia, obesity, glucose metabolism abnormalities, scoliosis, obstructive sleep apnea syndrome (OSAS) and behavioral problems. We report the case of a girl affected by PWS who presented at the age of 5.9 with premature pubarche, accelerated lin...

hrp0098fc11.3 | Fat, Metabolism and Obesity 2 | ESPE2024

Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters

Felicia Faienza Maria , Chiarito Mariangela , Aureli Alessia , Buganza Raffaele , Corica Domenico , Delvecchio Maurizio , De Sanctis Luisa , Fintini Danilo , Grugni Graziano , Rosaria Licenziati Maria , Madeo Simona , Mozzillo Enza , Rutigliano Irene , Valerio Giuliana

Introduction: Asprosin is a new discovered adipokine involved in the regulation of appetite, glucose, and energy homeostasis. The aim of our study was to evaluate asprosin serum levels in children and adults affected with Prader-Willi Syndrome (PWS), and to compare with hyperphagia questionnaire (HFQ), anthropometric and metabolic parameters.Methods: This cross-sectional study included 118 PWS subjects (88 children, mean...